Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The utilisation of glutamine and glucose by a 3-D tumour model trapped in quiescence.

Journal article

Smith H. et al, (2021), Int J Biochem Cell Biol

SF3B1 mutant myelodysplastic syndrome: Recent advances.

Journal article

Pellagatti A. and Boultwood J., (2020), Adv Biol Regul

DEFERASIROX TARGETS PHOSPHOLIPASE C BETA1 SIGNALING IN MYELODYSPLASTIC SYNDROMES (MDS)

Conference paper

Follo MY. et al, (2020), HAEMATOLOGICA, 105, S63 - S63

Spliceosome mutations: 1 plus 1 does not always equal 2.

Journal article

Pellagatti A. and Boultwood J., (2020), Blood, 136, 1471 - 1472

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.

Journal article

Bailey MH. et al, (2020), Nat Commun, 11

Sex differences in oncogenic mutational processes.

Journal article

Li CH. et al, (2020), Nat Commun, 11

Pan-cancer analysis of whole genomes.

Journal article

ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium None., (2020), Nature, 578, 82 - 93

Splicing factor mutant myelodysplastic syndromes: Recent advances.

Book

Pellagatti A. and Boultwood J., (2020), 75

Load More